Cohort (CHRT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Mar, 2026Leadership and experience
Executive team has decades of defence industry experience, including roles at major defence firms and the UK MOD.
Leadership continuity since foundation, with key executives serving since inception.
Strategic strengths and investment case
Proven business model with a focus on attractive growth markets and niche sectors.
Active acquisition strategy and strong financial position support R&D and capacity investment.
Consistent dividend growth since IPO and visibility of earnings into the mid-2030s.
Business segments and capabilities
Communications and Intelligence segment includes tactical/naval communications, C4I, satellite terminals, cyber security, and EW support.
Sensors and Effectors segment covers EO surveillance, fire control, counter-UAS, sonar, and underwater situational awareness.
Latest events from Cohort
- Record results, strong order book, and double-digit growth outlook driven by innovation and global demand.CHRT
Status update21 Jul 2026 - Record revenue, profit, and order book set a strong foundation for future growth.CHRT
H2 2026 Pre recorded15 Jul 2026 - Record revenue and profit, robust order book, and 20th consecutive year of dividend growth.CHRT
H2 202615 Jul 2026 - Record revenue, strong order book, and global demand drive confidence in sustained growth.CHRT
Investor Update9 Jul 2026 - Revenue and profit surpassed forecasts, with record orders and strong outlook for the next year.CHRT
Q4 2026 TU27 May 2026 - Record results, robust order book, and strong demand support a positive growth outlook.CHRT
H2 20243 Feb 2026 - Acquisition brings new tech, global reach, and strong financial upside in defense markets.CHRT
M&A Announcement13 Jan 2026 - Record revenue, strong order book, and global demand drive positive outlook and margin growth.CHRT
Investor Update12 Jan 2026 - Record revenue, profit, and order book set strong foundation for continued growth.CHRT
H1 202511 Jan 2026